In light of the events in recent months that have illuminated the plight of Black Americans, I continue to reflect on the role we must play in confronting racism and the devastating consequences of this persistent evil.
On June 26, 2020, the Centers for Disease Control (CDC) released a report entitled, “Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection — U.S. Public Health Service Guideline, 2020”.
It is with great sorrow that the American Society of Transplant Surgeons (ASTS) announces one of our own, Dr. Felicitas Koller and her husband, lost their 4-year-old son Tunis on Sunday in a tragic accident at home.
Critical Path Institute (C-Path) announced today that its Transplant Therapeutics Consortium (TTC) has received a positive response to its Letter of Intent (LOI) from the U.S. Food and Drug Administration (FDA) detailing the decision to accept the Composite Biomarker Panel (iBox Scoring System) into the Center for Drug Evaluation and Research (CDER) Biomarker Qualification Program (BQP).
In addition to the COVID-19 crisis, our country is now hurting in a very different way. The very city we were to be gathered in for this year’s ATC and many others around the country have erupted with demonstrations in the wake of George Floyd’s death.